v3.26.1
Segment Information
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company manages its operations as a single segment. The Company's Chief Operating Decision Maker ("CODM"), its Chief Executive Officer, manages the Company's operations on a consolidated basis for the purposes of assessing performance and making operating decisions. The segment measure of profit or loss is consolidated net (loss) income.

The following table presents selected financial information with respect to the Company's single operating segment for each period presented:

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Collaboration revenue$898 $1,950 $1,773 $22,508 
Less:
Research and development expenses
Direct research and development expenses
ENTR-601-447,213 4,446 11,968 9,180 
ENTR-601-453,029 4,576 6,631 7,435 
ENTR-601-501,727 2,040 3,096 2,732 
ENTR-601-511,260 2,855 3,597 3,681 
DMD franchise-wide(1)
3,486 1,712 5,225 1,712 
Collaboration services301 527 535 1,403 
Ocular programs
649 542 1,110 812 
Other preclinical and discovery406 682 1,006 1,669 
Unallocated research and development expenses
Personnel related (including stock-based compensation)11,795 13,231 23,837 25,987 
Facility related and other5,503 7,266 11,418 15,340 
Total research and development expenses35,369 37,877 68,423 69,951 
General and administrative expenses10,492 10,922 20,616 21,196 
Interest and other income2,235 3,924 4,859 8,365 
Provision for (benefit from) income taxes
35 178 73 178 
Net (loss) income
$(42,763)$(43,103)$(82,480)$(60,452)
(1)Represents manufacturing and clinical costs that support across the Company's product candidates targeting DMD.
Assets regularly provided to the CODM are consistent with those reported on the condensed consolidated balance sheets with particular emphasis on the Company's available liquidity, including its cash, cash equivalents and marketable securities balances. All of the Company's tangible assets are held in the United States.